Related Experiment Video

Updated: Sep 28, 2025

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.3K

Antibodies Against Cleaved CDCP1 Show Activity in RAS-Mutant Tumors

    Cancer Discovery
    |April 4, 2022
    PubMed

    Insights

    Targeting the cleaved form of CDCP1 (CUB-domain containing protein 1) demonstrated significant antitumor effects in solid tumor models, offering a promising new therapeutic strategy.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Drug Discovery

    Background:

    • CDCP1 (CUB-domain containing protein 1) is a transmembrane protein implicated in cancer progression.
    • The proteolytically cleaved form of CDCP1 plays a role in tumor growth and metastasis.

    Purpose of the Study:

    • To investigate the therapeutic potential of targeting the cleaved form of CDCP1.
    • To evaluate the antitumor activity of CDCP1-targeted therapies in solid tumor models.

    Main Methods:

    • Development of targeted agents against the cleaved CDCP1.
    • In vivo testing in established solid tumor models.
    • Assessment of tumor growth inhibition and related biomarkers.

    Main Results:

    • Targeting the cleaved CDCP1 resulted in significant inhibition of tumor growth.
    • Demonstrated antitumor activity across various solid tumor types.
    • Confirmed the role of cleaved CDCP1 as a viable therapeutic target.

    Conclusions:

    • The proteolytically cleaved form of CDCP1 is a validated target for cancer therapy.
    • Targeting cleaved CDCP1 holds promise for treating solid tumors.
    • Further development of CDCP1-based therapies is warranted.

    More Related Videos

    The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics10:31

    The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics

    Published on: October 6, 2016

    11.3K
    Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

    Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

    Published on: March 26, 2014

    23.5K

    Related Concept Videos

    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    4.7K
    The Ras Gene02:38

    The Ras Gene

    The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
    Ras is a...
    6.5K
    Inhibition of Cdk Activity02:34

    Inhibition of Cdk Activity

    The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
    5.0K
    Small GTPases - Ras and Rho01:24

    Small GTPases - Ras and Rho

    Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
    Three regulatory proteins control their activity:
    4.3K